Author details

Full Name

Wendy Kimryn Rathmell

Affiliation

ORCID

Career Start Year

1992

Papers

195

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
38061010	ASCO Ethical Guidance for the Practical Management of Oncology Drug Shortages.	J Clin Oncol	2024
36638190	Elevated transferrin receptor impairs T cell metabolism and function in systemic lupus erythematosus.		2023
36400581	Engineering functional 3-dimensional patient-derived endocrine organoids for broad multiplatform applications.	Surgery	2023
37892632	The Performance of Flash Replenishment Contrast-Enhanced Ultrasound for the Qualitative Assessment of Kidney Lesions in Patients with Chronic Kidney Disease.		2023
37722039	SETD2 safeguards the genome against isochromosome formation.	Proc Natl Acad Sci U S A	2023
37701598	LEARNING TO PIVOT: DEVELOPING TALENT AND A CHAMPIONSHIP TEAM.		2023
36973495	Immunogenicity in renal cell carcinoma: shifting focus to alternative sources of tumour-specific antigens.		2023
37146128	STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy.		2023
34949818	Spatial models of tumour evolution.	Nature Ecology and Evolution	2022
36371529	Glutathione peroxidase 4 inhibition induces ferroptosis and mTOR pathway suppression in thyroid cancer.	Scientific Reports	2022
35513776	Stimulating TAM-mediated anti-tumor immunity with mannose-decorated nanoparticles in ovarian cancer.	BMC Cancer	2022
36098684	A global view of the aspiring physician-scientist.	eLife	2022
35763345	Ligand-independent integrin Î²1 signaling supports lung adenocarcinoma development.	JCI Insight	2022
35954493	The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metastatic Renal Cell Carcinoma.	Cancers	2022
35995841	Uropathogenic Escherichia coli subverts mitochondrial metabolism to enable intracellular bacterial pathogenesis in urinary tract infection.	Nat Microbiol	2022
35676353	Mutation and tissue lineage lead to organ-specific cancer.	Nature	2022
35728020	Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline.	J Clin Oncol	2022
34239083	The therapeutic implications of immunosuppressive tumor aerobic glycolysis.	Cellular and Molecular Immunology	2022
34261605	Multiplatform computational analysis of mast cells in adrenocortical carcinoma tumor microenvironment.	Surgery	2022
34088993	Sunitinib and Axitinib increase secretion and glycolytic activity of small extracellular vesicles in renal cell carcinoma.	Cancer Gene Ther	2022
35315364	Pearls of wisdom for aspiring physician-scientist residency applicants and program directors.	JCI insight	2022
34857958	Apoptolidin family glycomacrolides target leukemia through inhibition of ATP synthase.	Nat Chem Biol	2022
34965942	From Basic Science to Clinical Translation in Kidney Cancer: A Report from the Second Kidney Cancer Research Summit.	Clin Cancer Res	2022
34818478	Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease.	N Engl J Med	2021
32359162	Summary From the First Kidney Cancer Research Summit, September 12-13, 2019: A Focus on Translational Research.	J Natl Cancer Inst	2021
34019793	Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages.	Cell	2021
33811077	A cytoskeletal function for PBRM1 reading methylated microtubules.	Sci Adv	2021
33806963	Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma.	Cancers (Basel)	2021
34014281	Neuronal SETD2 activity links microtubule methylation to an anxiety-like phenotype in mice.	Brain	2021
33463534	Pushing the boundaries with collision collaboration: the marriage of ideas.	Journal of Clinical Investigation	2021
34157286	Molecular determinants for Î±-tubulin methylation by SETD2.	Journal of Biological Chemistry	2021
33828302	Cell-programmed nutrient partitioning in the tumour microenvironment.	Nature	2021
34343338	Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement.	Cancer	2021
32936333	Evaluation, diagnosis and surveillance of renal masses in the setting of VHL disease.	World J Urol	2021
33144689	Clear cell renal cell carcinoma ontogeny and mechanisms of lethality.	Nature Reviews Nephrology	2021
33358149	Summary from the Kidney Cancer Association's Inaugural Think Thank: Coalition for a Cure.	Clin Genitourin Cancer	2021
34732251	Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma.	Biomarker Research	2021
34664400	Integrative computational immunogenomic profiling of cortisol-secreting adrenocortical carcinoma.	Journal of Cellular and Molecular Medicine	2021
34764458	Upcycling the TCA cycle-rewiring tumour-associated fibroblasts.	Nature Metabolism	2021
32771978	Fine-Needle Aspiration-Based Patient-Derived Cancer Organoids.	iScience	2020
32367803	The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy.	eLife	2020
32123314	Modeling clear cell renal cell carcinoma and therapeutic implications.	Oncogene	2020
32358509	PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma.	Nat Commun	2020
31763994	The 2019 Nobel Prize honors fundamental discoveries in hypoxia response.	Journal of Clinical Investigation	2020
32478677	Disruptions in the realm of medical science.	Journal of Clinical Investigation	2020
32493845	DNA hypomethylation promotes transposable element expression and activation of immune signaling in renal cell cancer.	JCI insight	2020
32147364	Pilot Study of [F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)/Magnetic Resonance Imaging (MRI) for Staging of Muscle-invasive Bladder Cancer (MIBC).		2020
33208553	Neoadjuvant pazopanib and molecular analysis of tissue response in renal cell carcinoma.	JCI Insight	2020
32814710	CD28 costimulation drives tumor-infiltrating T cell glycolysis to promote inflammation.	JCI Insight	2020
32512023	Beyond glycolysis: Hypoxia signaling as a master regulator of alternative metabolic pathways and the implications in clear cell renal cell carcinoma.	Cancer Letters	2020